Edwards Lifesciences Corporation (EW)

NYSE Currently up 3.93 (+4.93%) in today's trading session

3 members of Congress have disclosed 7 trades in Edwards Lifesciences Corporation (EW) via STOCK Act filings. The most recent disclosure was a sale by Josh Gottheimer on 19 November 2025. The most active traders have been Byron Donalds (4), Josh Gottheimer (2), and Susie Lee (1). Aggregate disclosed activity totals roughly $8K in purchases and $48K in sales (midpoint estimates from bracketed disclosure amounts).

Edwards Lifesciences Corporation is currently trading at $83.65, positioned at 73% of its 52-week range ($72.30 – $87.89).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Free asset at sign up • Eligible regions only
Live portfolio tracking
Automatic rebalancing

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Not available in the US.

Past Performance is not an indication of future results.

*Free asset promotion available at sign up in eligible regions only. Terms and conditions apply.

Current Price
$83.65
24h Change
+3.93 (+4.93%)
52 Week Range
$72.30$87.89
View on NASDAQ

Edwards Lifesciences Corporation Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for EW

Select to highlight on chart
3 transactions
Compliance: 43%
Josh Gottheimer19 Nov 202529 Dec 2025SaleStock$1,001 - $15,000N/A
Josh Gottheimer11 Dec 20237 Jan 2024PurchaseStock$1,001 - $15,000N/A
Susie Lee20 Mar 20198 Apr 2019SaleStock$1,001 - $15,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$48.46B

Volume

669.64K

Beta

0.94

P/E Ratio

46.44

Fundamentals

EPS

$1.81

Div. Yield

Open

$82.50

Day Range

$82.48 — $84.53

Company Information

Sector
Healthcare
Industry
Medical - Devices
Exchange
NYSE · USD
Country
US
CEO
Bernard J. Zovighian
IPO Date
2000-03-27

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement prod...

Earnings

Next Report

Q2 2026

23 Jul

EPS Est.

$0.75

Rev. Est.

$1.7B

Days Until

90

Recent Quarters

Q1 202623 Apr
EPS$0.78
Beat 7.0%
Q4 202510 Feb
EPS$0.58
Miss 6.2%
Q3 202530 Oct
EPS$0.67
Beat 12.4%
Q2 202524 Jul
EPS$0.67
Beat 7.4%
Q1 202523 Apr
EPS$0.64
Beat 7.4%
Q4 202411 Feb
EPS$0.59
Beat 7.1%
Q3 202424 Oct
EPS$0.67
Beat 0.8%
Q2 202424 Jul
EPS$0.70
Beat 1.4%
Q1 202425 Apr
EPS$0.66
Beat 3.1%
Q4 20236 Feb
EPS$0.64
Beat 0.0%
Q3 202325 Oct
EPS$0.59
Beat 0.0%
Q2 202326 Jul
EPS$0.66
Beat 1.5%
Q1 202326 Apr
EPS$0.62
Beat 1.6%
Q4 202231 Jan
EPS$0.64
Beat 4.9%
Q3 202227 Oct
EPS$0.61
Miss 1.6%
Q2 202228 Jul
EPS$0.63
Miss 1.6%
Q1 202226 Apr
EPS$0.60
Beat 5.3%
Q4 202126 Jan
EPS$0.51
Miss 7.3%
Q3 202127 Oct
EPS$0.54
Beat 1.9%
Q2 202129 Jul
EPS$0.64
Beat 14.3%
Q1 202120 Apr
EPS$0.54
Beat 14.9%
Q4 202027 Jan
EPS$0.50
Miss 5.7%
Q3 202021 Oct
EPS$0.51
Beat 15.9%
Q2 202023 Jul
EPS$0.34
Beat 126.7%
Q1 202023 Apr
EPS$0.50
Beat 13.6%
Q4 201930 Jan
EPS$0.49
Miss 2.0%
Q3 201923 Oct
EPS$0.47
Beat 14.6%
Q2 201923 Jul
EPS$0.46
Beat 4.5%
Q1 201923 Apr
EPS$0.44
Beat 7.3%
Q4 201831 Jan
EPS$0.39
Beat 0.0%
Q3 201823 Oct
EPS$0.36
Beat 5.9%
Q2 201826 Jul
EPS$0.41
Beat 7.9%
Q1 201824 Apr
EPS$0.41
Beat 10.8%
Q4 20171 Feb
EPS$0.31
Beat 3.3%
Q3 201724 Oct
EPS$0.28
Miss 3.5%
Q2 201726 Jul
EPS$0.32
Beat 10.3%
Q1 201725 Apr
EPS$0.31
Beat 14.8%
Q4 20161 Feb
EPS$0.25
Beat 4.2%
Q3 201625 Oct
EPS$0.23
Beat 0.0%
Q2 201626 Jul
EPS$0.25
Beat 8.7%
Q1 201626 Apr
EPS$0.24
Beat 9.1%
Q4 20152 Feb
EPS$0.21
Beat 0.0%
Q3 201526 Oct
EPS$0.18
Beat 12.5%
Q2 201528 Jul
EPS$0.19
Beat 5.6%
Q1 201523 Apr
EPS$0.19
Beat 11.8%
Q4 20143 Feb
EPS$0.18
Beat 12.5%
Q3 201423 Oct
EPS$0.13
Beat 8.3%
Q2 201429 Jul
EPS$0.15
Beat 15.4%
Q1 201424 Apr
EPS$0.13
Beat 18.2%
Q4 20133 Feb
EPS$0.15
Beat 7.1%
Q3 201328 Oct
EPS$0.11
Beat 0.0%
Q2 201325 Jul
EPS$0.14
Beat 7.7%
Q1 201323 Apr
EPS$0.12
Miss 7.7%
Q4 20124 Feb
EPS$0.15
Beat 15.4%
Q3 201219 Oct
EPS$0.10
Beat 11.1%
Q2 201224 Jul
EPS$0.11
Beat 0.0%
Q1 201224 Apr
EPS$0.09
Beat 12.5%
Q4 20112 Feb
EPS$0.10
Beat 0.0%
Q3 201119 Oct
EPS$0.06
Miss 14.3%
Q2 201121 Jul
EPS$0.08
Beat 0.0%
Q1 201120 Apr
EPS$0.09
Beat 28.6%
Q4 20102 Feb
EPS$0.09
Beat 0.0%
Q3 201025 Oct
EPS$0.07
Beat 0.0%
Q2 201021 Jul
EPS$0.08
Beat 14.3%
Q1 201020 Apr
EPS$0.07
Beat 0.0%
Q4 20094 Feb
EPS$0.07
Beat 0.0%
Q3 200921 Oct
EPS$0.06
Beat 0.0%
Q2 200920 Jul
EPS$0.07
Beat 16.7%
Q1 200927 Apr
EPS$0.06
Beat 0.0%
Q4 20083 Feb
EPS$0.07
Beat 16.7%
Q3 200821 Oct
EPS$0.05
Beat 0.0%
Q2 200822 Jul
EPS$0.06
Beat 20.0%
Q1 200822 Apr
EPS$0.05
Beat 13.9%
Q4 20075 Feb
EPS$0.05
Beat 6.4%
Q3 200722 Oct
EPS$0.04
Beat 7.9%
Q2 200723 Jul
EPS$0.05
Beat 0.0%
Q1 200723 Apr
EPS$0.05
Beat 0.0%
Q4 20065 Feb
EPS$0.05
Beat 3.7%
Q3 200619 Oct
EPS$0.04
Beat 0.8%
Q2 200624 Jul
EPS$0.05
Beat 8.0%
Q1 200620 Apr
EPS$0.04
Beat 3.0%
Q4 20052 Feb
EPS$0.04
Beat 3.9%
Q3 200525 Oct
EPS$0.04
Beat 1.6%
Q2 200521 Jul
EPS$0.04
Beat 7.1%
Q1 200521 Apr
EPS$0.04
Beat 6.4%
Q4 200427 Jan
EPS$0.04
Beat 2.2%
Q3 200421 Oct
EPS$0.03
Miss 1.0%
Q2 200427 Jul
EPS$0.04
Beat 4.2%
Q1 200422 Apr
EPS$0.03
Miss 0.2%
Q4 20033 Feb
EPS$0.04
Beat 6.7%
Q3 200320 Oct
EPS$0.03
Miss 4.4%
Q2 200322 Jul
EPS$0.03
Miss 0.9%
Q1 200322 Apr
EPS$0.03
Beat 11.7%
Q4 20023 Feb
EPS$0.03
Beat 5.5%
Q3 200222 Oct
EPS$0.03
Beat 1.6%
Q2 200223 Jul
EPS$0.03
Beat 2.6%
Q1 200223 Apr
EPS$0.03
Beat 6.7%
Q4 20015 Feb
EPS$0.02
Beat 2.0%
Q3 200125 Oct
EPS$0.02
Beat 3.2%
Q2 200126 Jul
EPS$0.02
Beat 7.3%
Q1 200126 Apr
EPS$0.02
Beat 7.3%
Q4 20006 Feb
EPS$0.02
Beat 10.1%
Q3 200031 Oct
EPS$0.02
Beat 0.0%
Q2 200024 Aug
EPS$-0.44
Miss 1206.1%
Q2 20008 Aug
EPS$0.02
Beat 0.0%
Q3 199931 Dec
EPS$0.09

4 politicians traded within 30 days

No dividend data available for this stock.

Stock Splits

Split History

1 Jun 2020Stock Split
Ratio3:1
14 Dec 2015Stock Split
Ratio2:1
28 May 2010Stock Split
Ratio2:1

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

NVDA

NVIDIA Corporation

20
$207.03+7.39 (+3.70%)
Technology
Held by same politician
Significant holdings value
1 politician
View Stock

PTSNX

PIMCO Short Term I-3

17
$9.680.00 (0.00%)
Held by same politician
1 politician
View Stock

NFLX

Netflix, Inc.

17
$92.37-0.45 (-0.48%)
Communication Services
Held by same politician
1 politician
View Stock

Frequently Asked Questions about EW

Which members of Congress have traded EW?
3 members of Congress have disclosed 7 trades in Edwards Lifesciences Corporation (EW) under the STOCK Act. The most active traders are Byron Donalds, Josh Gottheimer, and Susie Lee.
When was EW most recently disclosed by Congress?
The most recent EW disclosure was a sale by Josh Gottheimer on 19 November 2025.
What is the total disclosed congressional trading volume for EW?
Members of Congress have disclosed approximately $8K in EW purchases and $48K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in EW?
This EW page updates as soon as new STOCK Act disclosures are filed for Edwards Lifesciences Corporation. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi TrackerJoin our Discord © 2026 - All rights reserved. This website is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office, or her representatives. Any use of her name is solely for the purpose of discussing publicly available information.The information provided on this website is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.